Page last updated: 2024-08-21

chenodeoxycholic acid and Chronic Delta Hepatitis

chenodeoxycholic acid has been researched along with Chronic Delta Hepatitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchmann, B; Ciesek, S; Döhner, K; Manns, MP; Pinto Marques Souza de Oliveira, C; Sandmann, L; Sarrazin, C; Schlaphoff, V; Sodeik, B; Sprinzl, K; Veloso Alves Pereira, I; von Hahn, T; Vondran, F1

Other Studies

1 other study(ies) available for chenodeoxycholic acid and Chronic Delta Hepatitis

ArticleYear
Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Adult; Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line, Tumor; Chenodeoxycholic Acid; Coinfection; Extracellular Space; Female; Gene Expression Regulation, Neoplastic; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Liver Neoplasms; Male; Middle Aged; Organic Anion Transporters, Sodium-Dependent; Sodium; Symporters; Virus Internalization; Virus Replication

2015